SPECTRAMED INC &lt;SPMD.O> 3RD QTR NET
  Shr profit seven cts vs n/a
      Net profit 587,000 vs profit 3,231,000
      Sales 18.5 mln vs 18.7 mln
      Nine Mths
      Shr loss 39 ct s vs n/a
      Net loss 2,368,000 vs protit 7,165,000
      Sales 55.4 mln vs 54.2 mln
      Note: Current nine month figures include extraordinary loss
  of 1.2 mln dlrs, or 17 cts per share, resulting from costs
  associated with restructuring.
      Prior quarter and nine month per share figures not
  applicable because company began operations in October, 1986
  with the acquisition of Gould Inc's &lt;GLD> medical products
  group.
  

